Economic evaluation of human albumin use in patients with nephrotic syndrome in four Brazilian public hospitals: pharmacoeconomic study

Abstract

CONTEXT AND OBJECTIVE: In 2004, the Brazilian National Health Surveillance Agency (Agência Nacional de Vigilância Sanitária, ANVISA) published a resolution establishing guidelines for albumin use. Although the published data do not indicate any definitive conclusions about the benefits of albumin use in patients with nephrotic syndrome (NS), the guidelines recommend this procedure only in cases of edema that is refractory to use of diuretics.The aim here was to analyze albumin use among patients with nephrotic syndrome. DESIGN AND SETTING: Pharmacoeconomic study conducted in four large public referral hospitals for nephrology services in northeastern Brazil. METHOD: Cost-effectiveness and cost-utility economic evaluations were performed on a concurrent cohort of patients with nephrotic syndrome, who were divided into two groups according to compliance or noncompliance with the guidelines. Quality-of-life data were obtained from the SF36 and CHQ-PF50 questionnaires.RESULTS: This study enrolled 109 patients (60% adults and 56% women); 41.3% were using albumin in accordance with the guidelines. The weight, diuresis and fluid balance parameters were more cost-effective for patients who adhered to the guidelines. Regarding days of hospitalization avoided, the incremental ratio showed a daily cost of R$ 55.33, and guideline-compliant patients were hospitalized for five days or fewer. The quality of life improved by 8%, and savings of R$ 3,458.13/QALY (quality-adjusted life year) for the healthcare system were generated through guideline compliance. CONCLUSION:The economic analyses of this study demonstrated that there were greater cost benefits for patients whose treatment followed the guidelines. RESUMO

Tratamento Cirúrgico Da Síndrome Nefrótica: Estratégias Para O Controle Da Proteinúria E Preservação Da Função Renal

“…Recentes estudos destacam os impactos negativos da síndrome nefrótica (SN) na saúde física e mental, ressaltando como a condição pode afetar significativamente a qualidade de vida dos pacientes e de seus familiares. Lidar com uma condição crônica e recorrente como a SN, que frequentemente requer tratamentos complexos, monitoramento contínuo e controle dos sintomas, pode ser uma tarefa desafiadora (Toledo et al, 2017).…”

“…As complicações da SN, como o aumento do risco de doenças cardiovasculares e tromboembolismo, muitas vezes estão ligadas a desequilíbrios no metabolismo lipídico e à dislipidemia, que também podem contribuir para a progressão da doença renal (Toledo et al, 2017).…”